MC Comac Medical Ltd.
About MC Comac Medical Ltd.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Chiesi Farmaceutici S.p.A.
3
Astellas Pharma Europe B.V.
2
Hoffmann-La Roche
2
Medivir
2
Aquilon Pharmaceuticals S.A.
1
Bayer
1
Danone Research
1
Donesta Bioscience
1
EMD Serono Research & Development Institute, Inc.
1
Eli Lilly and Company
1
Estetra
1
Clinical Trials at MC Comac Medical Ltd.
During the past decade, MC Comac Medical Ltd. conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 5 clinical trials were completed, i.e. on
average, 31.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema
2013-11-01
2015-08-01
Terminated
199
A Study to Investigate the Effect of Severely Diminished Liver Function on the Metabolism, Safety, and Tolerability of a Single Oral Dose of Enzalutamide in Men
2013-08-01
2014-03-01
Completed
16
A Study to Investigate the Exposure and Safety and Tolerability of a Single Dose of FG-4592 in Subjects With Moderately Diminished Liver Function Compared to Those With Normal Liver Function
2013-09-01
2013-12-01
Completed
16
The Effect of Increased Water Intake on the Frequency of the Clinical Recurrent Urinary Tract Infections in Pre-menopausal Women: S-HYDRACYST
2013-12-01
2016-07-01
Completed
140
A Study to Evaluate the Efficacy, Safety and Tolerability of MIV-711 in Osteoarthritis Patients
2016-01-28
2017-05-23
Completed
244
A Study in Healthy Volunteers and in Participants With Chronic Hepatitis B to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7020531
2016-12-12
2021-06-15
Completed
46
A Study to Evaluate Safety and Tolerability of MIV-711 in Osteoarthritis Patients
2016-09-01
2017-11-28
Completed
50
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "MC Comac Medical Ltd." #1 sponsor was "Chiesi Farmaceutici S.p.A." with 3 trials, followed by "Astellas Pharma Europe B.V." with 2 trials
sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Medivir" with 2 trials sponsored and "Aquilon Pharmaceuticals S.A."
with 2 trials sponsored. Other sponsors include 5 different institutions and
companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "MC Comac Medical Ltd."
#1 collaborator was "Comac Medical" with 1 trials as a collaborator, "FibroGen" with 1 trials as a collaborator, "IQVIA RDS Ireland Ltd" with 1 trials as a collaborator, "Medivation, Inc." with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at MC Comac Medical Ltd.
According to Clinical.Site data, the most researched conditions in "MC Comac Medical Ltd." are
"Chronic Obstructive Pulmonary Disease" (2 trials), "Osteoarthritis, Knee" (2 trials), "Pharmacokinetics" (2 trials), "Chronic Kidney Disease" (1 trials) and "Contraception" (1 trials). Many other conditions were trialed in "MC Comac Medical Ltd." in a lesser frequency.
Clinical Trials Intervention Types at MC Comac Medical Ltd.
Most popular intervention types in "MC Comac Medical Ltd." are "Drug" (18 trials), "Other" (3 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "MIV-711" (2 trials), "15 mg E4 multiple-dose" (1 trials), "15 mg E4 single-dose" (1 trials) and "30 mg estetrol (E4)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MC Comac Medical Ltd.
The vast majority of trials in "MC Comac Medical Ltd." are
16 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at MC Comac Medical Ltd.
Currently, there are NaN active trials in "MC Comac Medical Ltd.".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 14 completed trials in MC Comac Medical Ltd.,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in MC Comac Medical Ltd., 15 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".